Why Inflammation Stays After Treatment
Breast cancer treatment — chemotherapy, radiation, hormone therapy — saves lives. But it also stresses the body. One consequence is that levels of inflammatory proteins (called cytokines) often stay elevated long after treatment ends.
Chronic inflammation is not just an abstract concern. Elevated levels of proteins like IL-6 and TNF-alpha (signaling molecules that drive inflammation) are linked to fatigue, depression, cardiovascular disease, and in some research, a higher risk of cancer recurrence. Helping survivors bring those levels down matters for quality of life and long-term health.
Exercise Was Already Known to Help
Doctors have known for years that exercise benefits cancer survivors. It improves mood, reduces fatigue, preserves muscle mass, and lowers cardiovascular risk. But the research on exercise and inflammation specifically had been scattered — different studies testing different types of exercise, at different doses, with different methods.
But here is the twist: this new analysis pulled all the available trial data together using a sophisticated statistical approach called network meta-analysis. Instead of just comparing exercise to no exercise, researchers could now compare aerobic exercise versus resistance training versus combined exercise versus low-intensity movement — all against each other simultaneously.
What Inflammation Actually Is
Your immune system uses inflammatory proteins as messengers. Think of them like emergency flares — useful in a crisis, but damaging if they never get put out.
When you exercise, muscles release their own chemical signals that interact with the immune system. Over time, regular moderate exercise teaches the body to produce fewer of these inflammatory flares at rest. The type of exercise you do determines which immune pathways get activated and how strongly.
What the Research Pool Covered
This systematic review and network meta-analysis analyzed 27 randomized controlled trials involving 1,925 breast cancer survivors. The trials tested four types of exercise programs: aerobic exercise alone (like walking, cycling, or swimming), resistance training alone (weights or bands), combined aerobic and resistance training, and low-intensity activity (like gentle stretching or yoga). Researchers tracked five inflammatory biomarkers: IL-6, TNF-alpha, hs-CRP (a general inflammation marker), IL-8, and IL-10 (an anti-inflammatory protein). They also examined how age and exercise dose affected results.
Combined exercise came out on top for the broadest anti-inflammatory effect. It had the highest probability of reducing IL-6, IL-8, and TNF-alpha — three of the most clinically important inflammatory proteins — compared to all other exercise types.
Aerobic exercise alone was most effective at reducing hs-CRP (a marker of general inflammation often tested in routine blood work). And low-intensity exercise, surprisingly, was most effective at raising IL-10 — the body's natural anti-inflammatory signal.
But there's a catch.
Age and Hormones Change the Picture
For women over 55, TNF-alpha tended to increase rather than decrease with most exercise types. This is likely linked to hormonal status — post-menopausal survivors may respond to exercise-driven immune signals differently. The takeaway is not to avoid exercise after 55, but rather that exercise prescriptions for older survivors may need to be carefully tailored.
There is no single exercise prescription that works best for every breast cancer survivor — age and hormonal status shape how your body responds.
The analysis also found a sweet spot for exercise dose: between 510 and 920 MET-minutes per week (a measure that accounts for both intensity and duration). Below that range, the anti-inflammatory effects were smaller. Above it, there was no clear added benefit.
If you are a breast cancer survivor, you do not need to wait for formal exercise oncology guidelines to start moving. The evidence strongly supports some form of regular physical activity. For maximum anti-inflammatory benefit, combining aerobic exercise with resistance training appears to be the most effective approach for most survivors. However, given the age-related differences found in this study, it is worth discussing your exercise plan with your oncologist or a certified exercise physiologist who works with cancer survivors. Starting conservatively and building gradually is both safe and effective.
The 27 trials in this analysis varied considerably in how they defined and measured exercise programs and inflammatory outcomes. The statistical heterogeneity was high, meaning results were not perfectly consistent across studies. Many trials were also short — typically weeks to a few months — making it harder to assess long-term effects. Most participants in the included trials were from higher-income countries, which may limit applicability to other populations.
Researchers are increasingly calling for standardized exercise protocols in cancer survivorship trials so future analyses can make cleaner comparisons. There is also growing interest in whether the anti-inflammatory benefits of exercise translate into lower rates of cancer recurrence — a question that will require very long follow-up periods to answer. In the near term, the field is moving toward personalized exercise prescriptions that account for age, hormonal status, treatment history, and baseline fitness level. The goal is to give survivors not just a recommendation to "be active," but a specific, evidence-based plan.
